Navigation Links
Therapeutic Revolution in Dermatology
Date:4/29/2010

Can several PDT sessions be applied if lesions recur?

Professor Lasse Braathen: Yes, because phototherapy involves no ionizing toxicity. When lesions reappear, the patient can again be offered treatment by PDT, and the treatment can be repeated as many times as necessary. In rare cases of failure, all therapeutic options are available because of the absence of local or general toxicity from PDT, with no loss of the patient's chances. When skin lesions are extensive, treatment by PDT makes it possible to pinpoint the "PDT-resistant" lesions that require some other therapeutic approach.

Are there other possible uses of PDT?

Professor Lasse Braathen: Yes, but they have not been validated by the AMM; some skin lymphomas can benefit from it, with remarkable effectiveness. PDT can also be used preventively in transplant patients, in whom skin cancer appears in 15% of cases after the transplant.

Cosmetic use of PDT is also practiced outside AMM for its "rejuvenating" effect. Patients presenting an actinic keratosis also benefit from this positive secondary effect of PDT.

The relatively recent concept of "field cancerization" could become an indication for PDT. A field cancerization around actinic keratosis lesions forms an area with pre-neoplastic anomalies and infra-clinical and multifocal genetic mutations that can evolve into primitive new tumours and local recurrences. It seems logical to treat all of this area preventively rather than to treat an isolated lesion. Applying Metvix makes it possible to more easily see the non-visible lesions, which glow under black light. This method is very much appreciated by patients, who can use it to see their skin risk and easily understand the need for treatme
'/>"/>

SOURCE European Society for Photodynamic Therapy (Euro PDT)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
2. Talecris Biotherapeutics to Report First Quarter 2010 Financial Results
3. Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.
4. Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics
5. invivodata Delivers Critical Symptom Relief Data in INSYS Therapeutics' Breakthrough Cancer Pain Trial
6. Michael J. Fox Foundation Offers High-Quality LRRK2 Antibodies for PD Therapeutic Development
7. Viron reports positive proof of concept results in arthritis for its VT-346 anti-TNF therapeutic
8. Cornerstone Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results
9. Foamix Ltd. and Therapeutics Inc. Enter Into Joint Venture to Develop New Prescription Foams for Inflammatory Skin Diseases - Will Target Over 20 Million Psoriasis and Atopic Dermatitis Patients
10. Sunlight Research(TM), Releases its Osiris Therapeutics Stem Cell Patent Report
11. Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MITs Technology Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... 20, 2015 This year has been ... lawns. US Patented Pearl’s Premium Ultra Low Maintenance ... the country that are coming out of record bad ... number of major global concerns related to water, health, ... – the alternative to the standard, water-wasting, chemical-treated standard ...
(Date:5/20/2015)... , May 20, 2015  Health eCareers, the ... healthcare organizations with job seekers looking for the ... a new mobile and online tool dedicated exclusively ... industry. SHIFT enables employers to quickly ... travel nursing, per diem and other temporary positions, ...
(Date:5/20/2015)... 20, 2015  Cypher Genomics, Inc., a leading ... Celgene Corporation to apply Cypher,s Coral TM ... with patient response to innovative medicines. The information ... accelerate patient access to the right medicine at ... and development and potentially inform new companion diagnostics.  ...
(Date:5/20/2015)... CA, Mulhouse, France, Cambridge, MA (PRWEB) May 20, ... provider of high quality transporter assay services for ... and Pharmacology, and Rhenovia Pharma, a world leader ... neurotransmission using Translational Quantitative Systems Pharmacology supported by ... partnership agreement. , The agreement allows both companies ...
Breaking Biology Technology:Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
... ... DGV databases enable researchers to quickly and effectively use these invaluable resources. , ... Seattle, WA (PRWEB) July 16, 2009 -- ... (GAD) and Database of Genomic Variants (DGV). The dbGaP resource is ...
... WILMINGTON, Del., July 15 ParagonRx, a healthcare consulting ... has filed its interim analysis of a study that shows ... of opioid drugs meet FDA standards for risk evaluation and ... to the FDA during public hearings earlier this year. , ...
... - Scientists in Atlantic Canada have found a gene that ... the genetic cause of a rare disorder known as cutis ... feet and face to be loose and older looking, as ... brain. In the process, researchers found some interesting correlations with ...
Cached Biology Technology:New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix 2New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix 3Canadian researchers discover gene related to the appearance of aging 2
(Date:5/21/2015)... 2015 The Sync Project™ , a ... health, today announced a collaborative partnership with Berklee,s ... center on collaboration on original research, joint course development ... the collaboration, The Sync Project and BerkleeICE are exploring ... in the 2015-2016 academic year.  The ...
(Date:5/19/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... drugs, such as Famotidine, Cimetidine and Ranitidine, approved in the ... the fetus according to a large collaborative cohort study by ... published in the Journal of Clinical Pharmacology provides ... blocker drugs are given to women to relieve acid ...
... This release is available in French . ... over 12 million people worldwide, with more than 2 million new ... the parasite survives inside human cells. That mystery has now been ... by a team led by Dr. Martin Olivier a ...
... cell division, whether hematopoietic stem cells (HSCs) will develop ... blood cells depends on a chemical process called DNA ... laboratory of Dr. Frank Rosenbauer of the Max Delbrck ... the laboratory of Professor Sten Eirik W. Jacobsen (Lund ...
Cached Biology News:Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers 2Major discovery opens door to leishmania treatment 2MDC scientists show how hematopoietic stem cell development is regulated 2
Human FADD Affinity Purified Polyclonal Ab...
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Biology Products: